Pharma By Number

Pharma By Number

PHARMA BY NUMBER

  • Industry spend 141.6 Billion USD on R&D per year
  • Drug Development for Particular Disease
    • o Cancer 1,813
    • o Diabetes 475
    • o HIV/AIDS 159
    • o Cardiovascular 559
  • 5 of the 10 Leading global R&D firms were Research – Base Biopharmaceutical companies
  • Annual Spending by the Biopharmaceutical: Industry is 5 times greater than the Defence & Aerospace Industries

PHARMA & GLOBAL HEALTH BETWEEN 2000-2008

  • VACCINE HELPED REDUCE NUMBER OF MEASLES DEATH IN AFRICA BY 92%
  • IN 2014 IFPMA MEMBERS HAD 186 ONGOING R&D PROJECTS REGARDING DIEASES OF THE DEVELOPING WORLD
  • 88% R&D projects for NTDs are in partnerships between IFPMA members companies and +80 partners from universities, public and private sector, and NGOs
  • We are 3 largest global funder in NTDs research
  • Our investments in NTD research reached USD 401.2 million in 2013
  • 8 R&D centers are dedicated solely to searching for new cures for NTDs
  • 500 million immunized since 2000


PHARMA ECONOMIC FOOTPRINT

  • Biopharmaceutical market will reach 1.3 trillion by 2018
  • In 2012, Biopharmaceutical industry added USD 436.8 Billion to the world GDP similar to the economy of a country like Argentina
  • The Global biopharmaceutical industry (including Generic) employed over 4.4 million and paid USD 91.3 Billion in salaries
  • Global Health Partnerships IFPMA members have a strong track record in building strategic alliances for global health
408/85, 19th Floor, Phaholyothin Place Bldg., Phaholyothin Road, Samsennai, Phayathai, Bangkok 10400 Thailand

Phone : (02) 619-0232-6
Fax : (02) 619-0237
Email : [email protected]
facebook.com/prem.health
PReMA Thailand